Skip to main content
SCM Lifescience Co., Ltd. logo

SCM Lifescience Co., Ltd. — Investor Relations & Filings

Ticker · 298060 ISIN · KR7298060005 KO Manufacturing
Open in API
Filings indexed 418 across all filing types
Latest filing 2021-03-26 Declaration of Voting R…
Country KR South Korea
Listing KO 298060

About SCM Lifescience Co., Ltd.

http://www.scmlifescience.com/en/

SCM Lifescience Co., Ltd. is a biotechnology company focused on developing high-purity, high-efficacy stem cell therapeutics for difficult-to-treat and incurable diseases. The company utilizes its proprietary source technology, the Subfractionation Culturing Method, to isolate and culture potent stem cells. Its pipeline consists of allogeneic stem cell therapies targeting immunological conditions, which are undergoing clinical trials. SCM Lifescience is also establishing mass production manufacturing processes using 3D bioreactor technology and expanding its research into induced pluripotent stem cells (iPSC) and tissue engineering. The company's business areas also include contract manufacturing (CMO), contract research, consulting, and cosmetics.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for SCM Lifescience. It details the outcomes of various agenda items such as the approval of financial statements, election of directors, and amendments to the articles of incorporation. This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it confirms the decisions made by shareholders during the meeting.
2021-03-26 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees and executives, including the purpose, exercise price, and vesting conditions. This type of disclosure regarding the issuance of new shares or stock options falls under the category of share issue or capital change announcements.
2021-03-26 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for SCM Life Science Co., Ltd. It includes details about the meeting date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and management reference materials. This document is a formal proxy statement/notice sent to shareholders to inform them of the upcoming Annual General Meeting (AGM) and to solicit their votes. In the context of the provided categories, this fits the 'Proxy Solicitation & Information Statement' (PSI) classification, as it provides the necessary information for shareholders to exercise their voting rights.
2021-03-23 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (SCM Lifescience) regarding a correction to a previously filed 'Change in Sales or Profit/Loss Structure' report. It details specific financial adjustments (operating profit, net income, etc.) due to external audit findings. Since this is a formal regulatory disclosure of financial performance changes rather than a full annual report, a conference call transcript, or a simple announcement of a report, it falls under the 'Regulatory Filings' category as a standard corporate disclosure. FY 2020
2021-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) titled '감사보고서 제출' (Submission of Audit Report). It provides the audit opinion, key financial data, and details regarding the audit process for the fiscal year. While it contains financial data, it is a standard regulatory disclosure announcement regarding the receipt and submission of the audit report, rather than the full annual report document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2020
2021-03-18 Korean
[첨부추가]사업보고서 (2020.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive financial report titled '재무제표에 대한 감사보고서' (Audit Report on Financial Statements) for SCM Lifescience Co., Ltd. It includes the independent auditor's report, balance sheet, income statement, statement of changes in equity, cash flow statement, and detailed notes to the financial statements for the fiscal year ending December 31, 2020. As it contains the full audited financial statements and the auditor's opinion, it is classified as an Audit Report (AR). FY 2020
2021-03-18 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.